Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1575)
All Articles published online
|
Oct 21, 2007 (publication date) through Jan 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen ZS, He F, Zeng FJ, Jiang JP, Du DF, Liu B. Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2007; 13(39): 5273-5276 [PMID: 17876900 DOI: 10.3748/wjg.v13.i39.5273] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i39/5273.htm |
| Number | Citing Articles |
| 1 |
Ali Zarrinpar, Fady Kaldas, Ronald W Busuttil. Liver transplantation for hepatocellular carcinoma: an update. Hepatobiliary & Pancreatic Diseases International 2011; 10(3): 234 doi: 10.1016/S1499-3872(11)60039-8
|
| 2 |
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann. Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 2023; 107(7): 1524 doi: 10.1097/TP.0000000000004487
|
| 3 |
Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clinical and Molecular Hepatology 2014; 20(2): 192 doi: 10.3350/cmh.2014.20.2.192
|
| 4 |
Jan Lerut, Eliano Bonaccorsi-Riani, Patrice Finet, Pierre Gianello. Minimization of steroids in liver transplantation. Transplant International 2009; 22(1): 2 doi: 10.1111/j.1432-2277.2008.00758.x
|
| 5 |
J.M. Kim, J.-W. Joh, S.-J. Kim, C.H.D. Kwon, S. Song, M. Shin, S.H. Hong, S.-K. Lee. Steroid Withdrawal in Adult Liver Transplantation: Occurrence at a Single Center. Transplantation Proceedings 2010; 42(10): 4132 doi: 10.1016/j.transproceed.2010.10.018
|
| 6 |
Cameron Fairfield, Luit Penninga, James Powell, Ewen M Harrison, Stephen J Wigmore. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD007606.pub3
|
| 7 |
Quirino Lai, Samuele Iesari, Armin Finkenstedt, Maria Hoppe-Lotichius, Maxime Foguenne, Konrad Lehner, Gerd Otto, Jan Lerut. Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: A multicenter European experience. Hepatobiliary & Pancreatic Diseases International 2019; 18(6): 517 doi: 10.1016/j.hbpd.2019.05.006
|
| 8 |
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende. 2023; : 129 doi: 10.1007/978-3-662-65736-2_8
|
| 9 |
Samir Parekh, James R. Spivey. Textbook of Organ Transplantation. 2014; : 869 doi: 10.1002/9781118873434.ch78
|
| 10 |
Ali Zarrinpar, Ronald W Busuttil. Immunomodulating options for liver transplant patients. Expert Review of Clinical Immunology 2012; 8(6): 565 doi: 10.1586/eci.12.47
|
| 11 |
Kwang-Woong Lee, Kyung-Suk Suh. Liver Transplantation for Advanced Hepatocellular Carcinoma. Korean Journal of Transplantation 2010; 24(1): 4 doi: 10.4285/jkstn.2010.24.1.4
|
| 12 |
An Bin Hu, Lin Wei Wu, Qiang Tai, Xiao Feng Zhu, Xiao Shun He. Safety and efficacy of four steroid‐minimization protocols in liver transplant recipients: 3‐year follow‐up in a single center. Journal of Digestive Diseases 2013; 14(1): 38 doi: 10.1111/1751-2980.12008
|
| 13 |
L A Orci, C Toso, G Mentha, P Morel, P E Majno. Systematic review and meta-analysis of the effect of perioperative steroids on ischaemia–reperfusion injury and surgical stress response in patients undergoing liver resection. British Journal of Surgery 2013; 100(5): 600 doi: 10.1002/bjs.9035
|
| 14 |
Yuan-Yuan Liu, Chang-Ping Li, Ming-Sheng Huai, Xiao-Meng Fu, Zhuang Cui, Lin-Lin Fan, Shu Zhang, Yuan Liu, Jun Ma, Guang Li, Zhong-Yang Shen, Song Guo Zheng. Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression. PLOS ONE 2015; 10(3): e0120939 doi: 10.1371/journal.pone.0120939
|
| 15 |
Kan Chen, Kwan Man, Herold J. Metselaar, Harry L. A. Janssen, Maikel P. Peppelenbosch, Qiuwei Pan. Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation. Liver Transplantation 2014; 20(3): 261 doi: 10.1002/lt.23806
|
| 16 |
Cameron Fairfield, Luit Penninga, James Powell, Ewen M Harrison, Stephen J Wigmore. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. Cochrane Database of Systematic Reviews 2018; 2018(4) doi: 10.1002/14651858.CD007606.pub4
|
| 17 |
Yung-Fong Tsai, Fu-Chao Liu, Chun-Yu Chen, Jr-Rung Lin, Huang-Ping Yu. Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Population-Based Cohort Study. Journal of Clinical Medicine 2021; 10(8): 1558 doi: 10.3390/jcm10081558
|
| 18 |
Jacob Zaemes, Muneeb Rehman, Coleman Smith, Ruth He. Immune Checkpoint Inhibitors - New Insights and Recent Progress. 2023; doi: 10.5772/intechopen.107097
|
| 19 |
Michael Charlton, Josh Levitsky, Bashar Aqel, John O'Grady, Julie Hemibach, Mary Rinella, John Fung, Marwan Ghabril, Ray Thomason, Patrizia Burra, Ester Coelho Little, Marina Berenguer, Abraham Shaked, James Trotter, John Roberts, Manuel Rodriguez-Davalos, Mohamed Rela, Elizabeth Pomfret, Caroline Heyrend, Juan Gallegos-Orozco, Faouzi Saliba. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation 2018; 102(5): 727 doi: 10.1097/TP.0000000000002147
|
| 20 |
Young‐Kyu Kim, Kwang‐Woong Lee, Seong Hoon Kim, Seong Yeon Cho, Sung‐Sik Han, Sang‐Jae Park. Early Steroid Withdrawal Regimen Prevents New‐Onset Diabetes Mellitus in Old‐Age Recipients After Living Donor Liver Transplantation. World Journal of Surgery 2012; 36(10): 2443 doi: 10.1007/s00268-012-1661-6
|
| 21 |
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng, Peter Starkel. Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma. PLoS ONE 2013; 8(8): e71251 doi: 10.1371/journal.pone.0071251
|
| 22 |
Jinyang Gu, Xingyu Wu, Lei Lu, Shu Zhang, Jianling Bai, Jun Wang, Jun Li, Yitao Ding. Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials. Hepatology International 2014; 8(2): 198 doi: 10.1007/s12072-014-9523-y
|